Dallas Salazar
IPOs, contrarian, long/short equity, long-term horizon

Aspen Aerogels' IPO Should Be Treated As A Case Study For What To Avoid

Aspen Aerogels, Inc. (NYSE:ASPN) recently held an IPO on 6/13/2014 and sold 7,500,000 shares at $11.00/share, considerably lower than the targeted range of $14.00-$16.00. The company raised proceeds of $82.5 million. The shares last closed at $10.25 for an IPO to date performance of -6.8%, leaving the company with a market cap of $211 million.

This article will make the argument that ASPN is worth considerably less than where it currently trades based on the company's distance from profitability, low visibility of positive cash flow generation in the near and mid terms, and because of the certain debt and/or dilution that will soon come to shareholders and the company. The company has many other problems that the article...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details